Famotidine: all 61 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Paracetamol and Ibuprofen With or Without Famotidine for Calcific Tendinitis of the ShoulderNot yet recruitingNCT07539961Not applicable
• A Study to Prevent Infantile Spasms RelapseRecruitingNCT06819670Phase 2
• Novel Strategies for Reducing Burn Scar ItchRecruitingNCT06801626Phase 3
• Famotidine and Antacids for Treatment of DyspepsiaRecruitingNCT06241183Phase 4
• Gastrointestinal Dysmotility on Aspiration RiskRecruitingNCT05455359Phase 4
• Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility TrialTerminatedNCT05946551Phase 3Results posted
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 PatientsTerminatedNCT05077969Phase 2Results posted
• PROUD Study - Preventing Opioid Use DisordersTerminatedNCT04766996Phase 4Results posted
• Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19CompletedNCT04724720Phase 2Results posted
• Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19TerminatedNCT04545008Phase 1Results posted
• Antihistamines in Eosinophilic EsophagitisTerminatedNCT04248712Phase 2Results posted
• Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary HypertensionCompletedNCT03554291Phase 2Results posted
• Histamine Glutamate Antagonism in StrokeCompletedNCT02142712Phase 2Results posted
• Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic ArthritisCompletedNCT01563185Phase 4Results posted
• A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)CompletedNCT01000818Phase 1Results posted
• Ulcer Prevention Study in Post Gastric Bypass PatientsCompletedNCT00557349Phase 4Results posted
• Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) TreatmentCompletedNCT00450216Phase 3Results posted
• Evaluate the Effects of Famotidine or Rabeprazole on the PK of NirogacestatCompletedNCT07171619Phase 1
• Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer PatientsCompletedNCT06265077Phase 1/2
• Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal SurgeryWithdrawnNCT05965492Phase 3
• A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy ParticipantsCompletedNCT05866627Phase 1
• Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)WithdrawnNCT05085574Phase 2
• Interest of Famotidine in Children With Sickle Cell DiseaseCompletedNCT05084521Phase 2/3
• LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)CompletedNCT05077332Phase 2
• A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy ParticipantsCompletedNCT04941755Phase 1
• Cetirizine and Famotidine for COVID-19WithdrawnNCT04836806Phase 4
• An Outpatient Study Investigating Non-prescription Treatments for COVID-19TerminatedNCT04621149Phase 2
• Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19)WithdrawnNCT04565392Phase 4
• Role of Famotidine in the Clinical Improvement of COVID-19 Patients.CompletedNCT04504240Phase 3
• I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill PatientsActive, not recruitingNCT04488081Phase 2
• Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy ParticipantsCompletedNCT04470778Phase 1
• Histamine H1/H2 Receptors and Training AdaptationsCompletedNCT04450134Not applicable
• A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.CompletedNCT04390334Phase 1
• A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy VolunteersCompletedNCT04209699Phase 1
• A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With FamotidineCompletedNCT04179071Phase 1
• A Study to Determine the Pharmacokinetic Profile of BMS-986165 TabletsCompletedNCT04065932Phase 1
• Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart DiseaseCompletedNCT03667703Phase 4
• Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy SubjectsCompletedNCT03451110Phase 1
• Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive CytologyCompletedNCT03330028Phase 1
• A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy SubjectsCompletedNCT03302845Phase 1
• A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult SubjectsCompletedNCT02922933Phase 1
• Anesthetics in Rhytidoplasty - A Comparison StudyCompletedNCT02410460Not applicable
• Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And FoodCompletedNCT02097329Phase 1
• Famotidine in SchizophreniaStatus unknownNCT01946295Phase 2/3
• Famotidine for Levodopa-induced Dyskinesia in PDCompletedNCT01937078Phase 2
• Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn EpisodesCompletedNCT01928888Phase 4
• Bioavailability Study of Famotidine Tablets 40 mg Under Fasting ConditionsCompletedNCT01511731Phase 1
• ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASACompletedNCT01408186Phase 3
• PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding UlcersCompletedNCT01180179Phase 4
• A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting ConditionCompletedNCT01079065Not applicable
• A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed ConditionCompletedNCT01079052Not applicable
• Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With AspirinCompletedNCT01062516Phase 4
• Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer DyspepsiaStatus unknownNCT00978159Phase 4
• Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or FamotidineCompletedNCT00950339Phase 4
• Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer ProphylaxisTerminatedNCT00839488Phase 4
• Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart DiseaseCompletedNCT00683111Phase 4
• Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care UnitCompletedNCT00633035Phase 4
• Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant SchizophreniaCompletedNCT00565175Phase 4
• Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected PatientsCompletedNCT00384904Phase 4
• Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/TenofovirCompletedNCT00365339Phase 1
• Famotidine in Subjects With Non-erosive Gastroesophageal Reflux DiseaseCompletedNCT00141960Phase 2/3

← Famotidine overview